American College of Rheumatology (ACR) guidance documents are an avenue for projects seeking ACR endorsement or collaboration that do not fit into existing ACR publication pathways but where clinical guidance is desired by the rheumatology community.
The ACR has developed clinical guidance documents for pediatric and adult patients in the context of the COVID-19 pandemic, including guidance summaries and published journal articles.
The ACR has published recommendations for the use of musculoskeletal ultrasonography in rheumatology clinical practice.
Musculoskeletal Ultrasound Guidance
The 2021 EULAR/ACR series of clinical guidance documents provide recommendations about identification, screening, diagnosis, treatment, follow up, and monitoring of patients with autoinflammatory diseases.
2021 EULAR/ACR Points to Consider for Diagnosis and Management of Autoinflammatory Type I Interferonopathies: CANDLE/PRAAS, SAVI and AGS
Published March 22, 2022
2021 EULAR/ACR Points to Consider for Diagnosis and Management of IL-1 Mediated Autoinflammatory Diseases CAPS, TRAPS, MKD and DIRA
Published May 27, 2022
2021 EULAR/ACR Points to Consider for Early Diagnosis and Management of HLH/MAS